Bacterial isolates associated with pelvic inflammatory disease among female patients attending some hospitals in abuja, Nigeria Original paper
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
-
Pelvic Inflammatory Disease (PID)
Pelvic Inflammatory Disease (PID)
OverviewPelvic Inflammatory Disease (PID) is a significant infection of the female upper reproductive tract, affecting the uterus, fallopian tubes, ovaries, and other surrounding pelvic structures. It is most commonly caused by sexually transmitted infections (STIs), particularly Chlamydia trachomatis and Neisseria gonorrhoeae. These infections ascend from the cervix or vagina into the upper genital tract, where […]
-
Divine Aleru
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
What was studied?
This study focused on the bacterial isolates associated with pelvic inflammatory disease (PID) in female patients attending hospitals in Abuja, Nigeria. Researchers collected endocervical swabs from 100 women diagnosed with PID and analyzed the bacterial pathogens present using cultural and biochemical tests. The study aimed to identify the specific microorganisms causing PID in the region, their resistance to antibiotics, and the factors contributing to the disease’s occurrence. This research is particularly significant as PID is a prevalent but underreported health issue, and understanding the microbiological landscape can help guide treatment strategies.
Who was studied?
The study involved 100 women diagnosed with PID, attending various hospitals in Abuja, Nigeria. The participants were primarily women of reproductive age, with confirmed cases of PID based on clinical symptoms and laboratory findings. The study population also included women from various socio-demographic backgrounds, with a focus on understanding how factors like marital status, age, and sexual behavior influenced PID prevalence. These women were selected based on clinical criteria, such as a history of recurrent lower abdominal pain, cervical tenderness, and elevated white blood cell count, which are indicative of PID.
What were the most important findings?
The study identified several bacterial pathogens responsible for PID in the region, with Staphylococcus aureus being the most prevalent isolate (16%), followed by Escherichia coli (10%), Streptococcus faecalis (8%), and others such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Proteus species. 55% of the samples yielded no bacterial growth, suggesting that PID may also involve pathogens that are not detectable through conventional culturing methods. The study also highlighted that polygamous married women were the most affected group (90%), followed by singles (50%). Women in the 25-35 years age group had the highest incidence, while those aged 36-45 had the least. This age-related trend might be associated with sexual activity, as younger women are more likely to engage in high-risk behaviors. In terms of antibiotic resistance, Cefotaxime emerged as the most effective treatment for both Gram-positive and Gram-negative bacteria, indicating its potential use as a frontline treatment for PID.
What are the greatest implications of this study?
The findings from this study highlight the importance of understanding the local microbial landscape when diagnosing and treating PID. The identification of Staphylococcus aureus and Escherichia coli as the dominant pathogens highlights the need for targeted antibiotic therapy. The study also emphasizes the need for healthcare providers to consider socio-demographic factors, such as marital status and age, when addressing PID risks in women. The high prevalence of PID among polygamous women calls for focused public health interventions, including education on safe sexual practices and the promotion of early diagnosis and treatment. Moreover, the high occurrence of PID in the reproductive age group (25-35 years) suggests that sexual health education, coupled with routine screening for STIs and PID, could help reduce the incidence of this disease.